• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性微生物组与 HIV 预防策略。

The microbiome and HIV prevention strategies in women.

机构信息

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.

Department of Epidemiology, Columbia University, New York, New York, USA.

出版信息

Curr Opin HIV AIDS. 2018 Jan;13(1):81-87. doi: 10.1097/COH.0000000000000431.

DOI:10.1097/COH.0000000000000431
PMID:29059077
Abstract

PURPOSE OF REVIEW

HIV prevention approaches that women can use and control are a priority. Results from topical and oral preexposure prophylaxis (PrEP) HIV prevention trials have produced inconsistent results in women. One of the main behavioural factors impacting effectiveness of PrEP has been suboptimal adherence. In this review, we examine biological factors that modulate topical PrEP efficacy, with particular focus on the vaginal microbiome.

RECENT FINDINGS

Genital inflammation is an independent risk factor for HIV acquisition in women. Using 16S rRNA sequencing of the vaginal microbiota, anaerobic bacteria linked with bacterial vaginosis have been shown to be associated with both genital inflammation and HIV risk. Using proteomics, it was recently discovered that a dysbiotic vaginal microbiome, comprising less than 50% Lactobacillus spp., directly influenced topical PrEP efficacy. Gardnerella vaginalis, the dominant vaginal species in dysbiotic women, was able to directly degrade tenofovir, but not dapivirine, an antiretroviral also being developed for topical PrEP.

SUMMARY

The link between bacterial vaginosis-associated organisms with HIV risk and altered tenofovir gel effectiveness underscores the importance of good vaginal health and good adherence for women to benefit maximally from topical PrEP. Altering the vaginal microbiome is one of the new directions being pursued for HIV prevention.

摘要

目的综述:女性可使用和控制的艾滋病预防方法是重中之重。局部和口服暴露前预防(PrEP)艾滋病预防试验的结果在女性中产生了不一致的结果。影响 PrEP 效果的主要行为因素之一是用药依从性差。在这篇综述中,我们研究了调节局部 PrEP 疗效的生物学因素,特别关注阴道微生物组。

最新发现:生殖器炎症是女性获得性艾滋病的一个独立危险因素。使用阴道微生物组的 16S rRNA 测序,与细菌性阴道病相关的厌氧菌已被证明与生殖器炎症和 HIV 风险都有关。最近通过蛋白质组学发现,一种由少于 50%的乳杆菌属组成的失调阴道微生物组,直接影响局部 PrEP 的疗效。在失调的女性中占主导地位的阴道物种加德纳菌能够直接降解替诺福韦,但不能降解也在开发用于局部 PrEP 的抗逆转录病毒药物双夫定。

总结:细菌性阴道病相关病原体与 HIV 风险之间的联系以及改变替诺福韦凝胶有效性,突显了良好的阴道健康和良好的用药依从性对女性从局部 PrEP 中最大程度获益的重要性。改变阴道微生物组是预防艾滋病的新方向之一。

相似文献

1
The microbiome and HIV prevention strategies in women.女性微生物组与 HIV 预防策略。
Curr Opin HIV AIDS. 2018 Jan;13(1):81-87. doi: 10.1097/COH.0000000000000431.
2
The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.阴道微生物群及其对女性HIV暴露前预防疗效的潜在影响。
Curr HIV/AIDS Rep. 2017 Oct;14(5):153-160. doi: 10.1007/s11904-017-0362-z.
3
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.口服暴露前预防(PrEP)对阴道微生态异常女性中 HIV 有效性的影响:随机、安慰剂对照的 Partners PrEP 研究的事后分析。
Lancet HIV. 2017 Oct;4(10):e449-e456. doi: 10.1016/S2352-3018(17)30110-8. Epub 2017 Jul 18.
4
Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.阴道微生物群落对 HIV 基于抗逆转录病毒的暴露前预防 (PrEP) 药物代谢的影响。
PLoS Pathog. 2020 Dec 3;16(12):e1009024. doi: 10.1371/journal.ppat.1009024. eCollection 2020 Dec.
5
The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.生殖道和直肠微生物组:它们在女性 HIV 易感性和预防中的作用。
J Int AIDS Soc. 2019 May;22(5):e25300. doi: 10.1002/jia2.25300.
6
Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women.南非女性的阴道微生物转变不受口服暴露前预防的影响。
Sci Rep. 2022 Sep 28;12(1):16187. doi: 10.1038/s41598-022-20486-z.
7
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.阴道细菌会降低非洲女性使用替诺福韦艾滋病微凝胶的疗效。
Science. 2017 Jun 2;356(6341):938-945. doi: 10.1126/science.aai9383.
8
Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics.阴道微生物组调节局部抗逆转录病毒药物的药代动力学。
JCI Insight. 2018 Jul 12;3(13):99545. doi: 10.1172/jci.insight.99545.
9
The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.宫颈阴道微生物群对黏膜免疫和预防 HIV 感染的影响。
Curr HIV/AIDS Rep. 2018 Feb;15(1):30-38. doi: 10.1007/s11904-018-0380-5.
10
Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP.生殖器炎症与口服暴露前预防(PrEP)女性阴道替诺福韦浓度降低无关。
J Acquir Immune Defic Syndr. 2022 Apr 1;89(4):390-395. doi: 10.1097/QAI.0000000000002884.

引用本文的文献

1
Characterization of the Ovine Vaginal Microbiome and Inflammation Patterns as an Improved Testing Model of Human Vaginal Irritation.绵羊阴道微生物群和炎症模式的特征作为人类阴道刺激的改进测试模型
Front Reprod Health. 2021 Dec 7;3:714829. doi: 10.3389/frph.2021.714829. eCollection 2021.
2
An overview of implementing an evidence based program to increase HPV vaccination in HIV community clinics.在 HIV 社区诊所实施基于证据的项目以增加 HPV 疫苗接种率概述。
BMC Public Health. 2022 Sep 7;22(1):1696. doi: 10.1186/s12889-022-14100-0.
3
Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
地蒽酚和安慰剂阴道环对青少年、哺乳期和绝经后女性菌群的影响。
J Infect Dis. 2022 Jun 15;225(12):2208-2218. doi: 10.1093/infdis/jiab590.
4
Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.解析黏膜免疫反应和宫颈阴道微生物组在 HIV 暴露血清阴性(HESN)女性中抵抗 HIV 感染的作用。
Microbiol Spectr. 2021 Oct 31;9(2):e0047021. doi: 10.1128/Spectrum.00470-21. Epub 2021 Oct 27.
5
Evidence of HIV-1 Genital Shedding after One Year of Antiretroviral Therapy in Females Recently Diagnosed in Bamako, Mali.在马里巴马科最近诊断出的女性中,接受抗逆转录病毒治疗一年后HIV-1生殖器脱落的证据。
Microorganisms. 2021 Oct 17;9(10):2164. doi: 10.3390/microorganisms9102164.
6
Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells.人类肛门生殖器单核细胞衍生的树突状细胞和朗格汉斯细胞+cDC2 是 HIV 的主要靶细胞。
Nat Commun. 2021 Apr 12;12(1):2147. doi: 10.1038/s41467-021-22375-x.
7
Identifying Adolescent Girls and Young Women at High Risk for HIV Acquisition: A Risk Assessment Tool From the Girl Power-Malawi Study.识别处于 HIV 感染高风险的青少年女孩和年轻女性:来自 Girl Power-Malawi 研究的风险评估工具。
Sex Transm Dis. 2020 Nov;47(11):760-766. doi: 10.1097/OLQ.0000000000001242.
8
The Effect of Antiretroviral Therapy Initiation on the Vaginal Microbiome in HIV-Infected Women.抗逆转录病毒疗法起始对HIV感染女性阴道微生物群的影响。
Open Forum Infect Dis. 2019 Jul 12;6(9):ofz328. doi: 10.1093/ofid/ofz328. eCollection 2019 Sep.
9
Manipulation of Mononuclear Phagocytes by HIV: Implications for Early Transmission Events.HIV 对单核吞噬细胞的影响:对早期传播事件的影响。
Front Immunol. 2019 Sep 24;10:2263. doi: 10.3389/fimmu.2019.02263. eCollection 2019.
10
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.一项探索性试点研究评估了在南非细菌性阴道病女性中,标准抗生素治疗联合益生菌乳杆菌补充治疗的效果。
BMC Infect Dis. 2019 Sep 18;19(1):824. doi: 10.1186/s12879-019-4425-1.